<?xml version="1.0" encoding="UTF-8"?>
<p>As the demand for medicinal plants in the domestic and international pharmaceutical markets has increased, artificial cultivation has had a positive effect on the protection of wild resources and has allowed market demands to be met (
 <xref rid="B22" ref-type="bibr">Kling, 2016</xref>; 
 <xref rid="B11" ref-type="bibr">Cunningham et al., 2018</xref>). Since 1950, cultivated RA products have gradually replaced wild materials. The cultivated 
 <italic>A. membranaceus</italic> var. 
 <italic>mongholicus</italic> is a major source of RA, which accounts for an 80% share of the market (
 <xref rid="B28" ref-type="bibr">Sinclair, 1998</xref>; 
 <xref rid="B26" ref-type="bibr">Qin et al., 2013</xref>). Based on their particular natural conditions, ecological environments, cultivation technology, and postharvest processing methods involved (
 <xref rid="B21" ref-type="bibr">Huang et al., 2011</xref>), the Midwest area of Inner Mongolia and north Shanxi Province have been considered as “
 <italic>daodi</italic>” areas for RA (an area producing top quality herbal medicine). While the demand for RA is increasing, its cultivation has expanded from 
 <italic>daodi</italic> areas to many other production areas, such as Gansu, Shaanxi, Ningxia, and Hebei Provinces (
 <xref rid="B39" ref-type="bibr">Zhang et al., 2019</xref>). The cultivation area and 
 <italic>daodi</italic> region of RA are illustrated in 
 <xref ref-type="fig" rid="F1">Figure 1</xref>.
</p>
